FHLC logo

FHLCFidelity MSCI Health Care Index ETF

$74.25
$0.18
(0.25%)
Today
Closed $73.44
$0.81
(1.10%)
After Hours
Updated: 07:23 PM EDT
Vol626,118.00
52W High$77.10
52W Low$61.11
News
all
press releases
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Sector ETF report for FHLC
Zacks
News Placeholder
More News
News Placeholder
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Sector ETF report for FHLC
Zacks
News Placeholder
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Sector ETF report for FHLC
Zacks
News Placeholder
FDA To Ease Review Process For Life-Saving Gene-Editing Therapies: Report
Vinay Prasad told Bloomberg that the FDA is going to be “extremely flexible” regarding gene editing therapies.
Stocktwits
News Placeholder
UnitedHealth Lifts EPS Outlook Despite Mixed Q3 Results: ETFs in Focus
UNH posts mixed Q3 results with a revenue miss but lifts its 2025 EPS outlook, boosting interest in healthcare ETFs like IHF and XLV.
Zacks
News Placeholder
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook
JNJ's Q3 earnings beat and raised 2025 sales outlook could lift healthcare ETFs like IHE, XLV and IYH, heavily weighted toward the drugmaker.
Zacks
News Placeholder
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study
The company stated that the continued effects and consistent benefits observed with repeat dosing in the trial support the potential of BXCL501 for use in the outpatient setting.
Stocktwits
News Placeholder
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
The company said that no discontinuations due to tolerability were observed in the arm of the study that received BXCL501.
Stocktwits
News Placeholder
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Sector ETF report for FHLC
Zacks
<
...
1
>

Advertisement|Remove ads.